Cyclic ureas useful as antiarrhythmic and antifibrillatory agent

Details Cyclic ureas useful as antiarrhythmic and antifibrillatory agent Cyclic ureas useful as antiarrhythmic and antifibrillatory agent

1995-06-07

1997-11-25

Gupta, Yogendra N.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

5142358, 514252, 514255, 514274, 514326, 544139, 544315, 544316, 544318, 544367, 544370, 546210, 5483157, 5483164, 5483225, A61K 31415, A61K 31505, C07D23302, C07D24104

Patent

active

056913699

ABSTRACT:
The cyclic ureas, and the pharmaceutically-acceptable salts and esters thereof, of the present invention are useful as antiarrhythmic and antifibrillatory agents and have the following general structure: ##STR1## wherein X, Y, A, L, R, R.sub.1, R.sub.2, R.sub.3, R.sub.4, and R.sub.5 are defined as in the Specification.

REFERENCES:
patent: 3254075 (1966-05-01), Ebetino
patent: 3415821 (1968-12-01), Davis et al.
patent: 3992374 (1976-11-01), Rufer et al.
patent: 4393204 (1983-07-01), Pelosi, Jr.
patent: 4543359 (1985-09-01), Ellis et al.
patent: 4689341 (1987-08-01), Diamond et al.
patent: 4705799 (1987-11-01), Gregory
patent: 4707499 (1987-11-01), Baran et al.
patent: 4713832 (1987-12-01), Pascal
patent: 4720580 (1988-01-01), Buzby et al.
patent: 4775670 (1988-10-01), Sykes et al.
patent: 4870095 (1989-09-01), Bailey
patent: 4876262 (1989-10-01), Oinuma et al.
patent: 4963561 (1990-10-01), Lesher et al.
patent: 4966967 (1990-10-01), Lumma, Jr. et al.
Bigger, J. T. and Hoffman, B. F., "Antiarrhythmic Drugs", Ch. 35 in Goodman and Gilman's The Basis of Pharmaceutical Therapeutics, 8th ed., ed., A. G. Gilman, pp. 840-873.
Bigger, J. T., "Antiarrhythmic Treatment: An Overview", American Journal of Cardiology, vol. 53, pp. 8B-16B, Feb. 27, 1984.
Woosley, R. L., "Antiarrhythmic Agents", in The Heart, Ch. 95, pp. 1682-1711, ed. J. W. Hurst, New York, McGraw-Hill (1990).
Woosley, R. L., "Antiarrhythmic Drugs", Annual Review. Pharmacology and Toxicology, vol. 31, pp. 427-455 (1991).
Morganroth, J. and Biggger, J. T., "Pharmacological Managment of Ventricular Arrhythmias After the Cardiac Arrhythmia Suppression Trial", American Journal of Cardiology, vol. 65, pp. 1497-1503 (1990).
Goldstein, S., "Toward a New Understanding of the Mechanism and Prevention of Sudden Death in Coronary Heart Disease", Circulation, vol. 82(1):pp. 284-288 (1990).
Echt, D. S. et al. "Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo: The Cardiac Arrhythmia Suppression Trial", New England Journal of Medicine, vol. 324, pp. 781-788 (1991).
Coplen, S. E. et al. "Efficacy and Safety of Quinidine Therapy for Maintenance of Sinus Rhythm After Cardioversion: A Meta-analysis" Circulation, vol. 82, pp. 1106-1116 (1990).

Affiliated with

Also associated with

Rating

Cyclic ureas useful as antiarrhythmic and antifibrillatory agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic ureas useful as antiarrhythmic and antifibrillatory agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic ureas useful as antiarrhythmic and antifibrillatory agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2107465